The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_000441.2(SLC26A4):c.1708-18T>A

CA4432923

256155 (ClinVar)

Gene: SLC26A4
Condition: Pendred syndrome
Inheritance Mode: Autosomal recessive inheritance
UUID: 9aa2ed65-e713-4357-b0b9-2fbfe5898a07
Approved on: 2020-03-18
Published on: 2020-03-19

HGVS expressions

NM_000441.2:c.1708-18T>A
NM_000441.2(SLC26A4):c.1708-18T>A
NC_000007.14:g.107701083T>A
CM000669.2:g.107701083T>A
NC_000007.13:g.107341528T>A
CM000669.1:g.107341528T>A
NC_000007.12:g.107128764T>A
NG_008489.1:g.45449T>A
NM_000441.1:c.1708-18T>A
ENST00000265715.7:c.1708-18T>A
ENST00000480841.5:n.557-18T>A
ENST00000492030.2:n.91-744T>A
More

Benign

Met criteria codes 3
BA1 BP4 BP7

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Hearing Loss VCEP
The filtering allele frequency (the lower threshold of the 95% CI of 1456/25104) of the c.1708-18T>A variant in the SLC26A4 gene is 5.55% for European (Finnish) chromosomes by gnomAD v2.1.1, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). This silent variant in SLC26A4 is not predicted by the computational prediction analysis using MaxEntScan to impact splicing (BP7, BP4). In summary, this variant meets criteria to be classified as benign. ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: BA1, BP7, BP4.
Met criteria codes
BA1
The variant is present in 5.55% (1456/25104) (95% CI) of European (Finnish) chromosomes in gnomAD v2.1.1 and in 5.35% (599/10464) (95% CI) of European (Finnish) chromosomes in gnomAD v3.
BP4
No splicing impact indicated by Alamut, squirrel and manatee have different nucleotides at this position.
BP7
No splicing effects indicated by predictors in Alamut including MaxEntScan.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.